2019
DOI: 10.1016/j.intimp.2019.105877
|View full text |Cite
|
Sign up to set email alerts
|

RvD1 ameliorates LPS-induced acute lung injury via the suppression of neutrophil infiltration by reducing CXCL2 expression and release from resident alveolar macrophages

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
44
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 52 publications
(46 citation statements)
references
References 37 publications
2
44
0
Order By: Relevance
“…These findings supported also by results of animal studies [ 225 , 226 , 227 ], may suggest a potential role for EPA and DHA in reducing the lung injury supporting the resolution of inflammation, probably via the production of SPMs [ 207 ]. However, further trials are needed to support this hypothesis.…”
Section: Omega-3 Fatty Acidssupporting
confidence: 60%
“…These findings supported also by results of animal studies [ 225 , 226 , 227 ], may suggest a potential role for EPA and DHA in reducing the lung injury supporting the resolution of inflammation, probably via the production of SPMs [ 207 ]. However, further trials are needed to support this hypothesis.…”
Section: Omega-3 Fatty Acidssupporting
confidence: 60%
“…This could be very important in the context of severe COVID-19 which manifests as uncontrolled inflammation, the so-called cytokine storm [18,19], linked with acute respiratory distress syndrome (ARDS). A number of the SPMs formed from EPA and DHA have been shown in animal models to both protect against and resolve acute lung injury and ARDS [20][21][22][23][24]. Nutritional formulas containing antioxidants and rich in EPA and DHA have been used in several human trials of patients with ARDS.…”
Section: Nutritional Impact On Immunitymentioning
confidence: 99%
“…In the present study, cAMP concentrations in lung tissue were lower in the LPS group compared with these in the Control group (Figure 4b), while these were higher in the LPS + PCTR1 group than these in the LPS group (Figure 4b), indicating that PCTR1 treatment could increase cAMP concentrations in the LPS-induced ALI model. The specific receptor for PCTR1 was unclear, while ALX was a common receptor for several SPMs Yang et al, 2019;H. W. Zhang, Wang, et al, 2019).…”
Section: Pctr1 Improved Lps-suppressed Lyve-1 Expression In Vivomentioning
confidence: 99%
“…Earlier studies from our group demonstrated that specialized proresolving mediators (SPMs) are derived from essential fatty acids and are actively biosynthesized in the resolution phase of acute inflammation, playing a key role in organ protection and inflammatory resolution (Jin et al, 2018;Yang et al, 2019;H. W. Zhang, Wang, et al, 2019;Zhuo et al, 2018).…”
mentioning
confidence: 99%